蔡司新一代机器人全飞秒VISUMAX 800
Search documents
宁波鄞州眼科开启10秒摘镜时代,新一代机器人全飞秒VISUMAX 800正式入驻
Jiang Nan Shi Bao· 2025-12-25 04:04
12月24日,华厦眼科(301267)医院集团宁波鄞州眼科医院正式引进"蔡司新一代机器人全飞秒 VISUMAX 800",并同步推出新微创手术SMILE pro。这一设备的落地,标志着医院屈光手术正式迈 入"超快、智能、更安全"的新时代!将为广大近视、散光患者带来更优质的摘镜体验。 专家解读:三大优势惠及患者 宁波鄞州眼科医院以黄旭院长为核心的屈光专家团队,累计完成全飞秒等各类屈光手术数万例。为确保 全飞秒SMILE pro在临床安全、规范地应用,黄旭院长已提前通过"蔡司VISUMAX 800"官方实操认证。 长期以来,医院坚持以患者为中心,将设备迭代升级与人才培养、学科建设深度融合,凭借专业实力成 为尖端设备落地的优选之地。最终目标,是让宁波市民在家门口就能便捷享受到与国际同步的优质屈光 服务。 紧跟前沿:以先进技术服务甬城市民 "引进这台设备,核心就是让宁波患者摘镜更顺畅、更放心。"宁波鄞州眼科医院屈光专家黄旭院长在现 场用通俗的语言解读了VISUMAX 800的核心优势。 10秒完成关键步骤,紧张感降低。以前做全飞秒,单眼激光扫描约23秒,这台设备的激光频率和扫描速 度大幅提升,10秒内就能完成核心扫描 ...
【华创医疗服务前瞻系列1】屈光专题:新术式、新需求
华创医药组公众平台· 2025-03-07 08:59
Group 1 - Refractive surgery is a surgical procedure that corrects vision by altering the eye's refractive system, primarily targeting myopia, hyperopia, and astigmatism [3] - The refractive surgery market is experiencing a new wave of transformation driven by advanced technologies such as precise femtosecond laser 4.0, all-light sculpting, and EVO+ICL, which are expected to significantly increase the average transaction price [1][2] - The domestic refractive surgery market was nearly 35 billion yuan in 2022, with a low penetration rate of 0.7 surgeries per thousand people in 2021, indicating substantial room for growth compared to developed countries like the US, which had 2.6 surgeries per thousand people [1][30] Group 2 - The refractive surgery sector is a core business in private ophthalmology, contributing significantly to profit growth due to its large market size and strong profitability [1][41] - The introduction of new technologies and equipment is anticipated to stimulate demand, leading to a potential price increase in refractive surgeries, alongside a recovery in consumer expectations [1][41] - Companies such as Aier Eye Hospital, Huaxia Eye Hospital, and others are recommended for attention due to their positioning in the growing refractive surgery market [1][41] Group 3 - The evolution of refractive surgery equipment has been steady, with significant advancements occurring approximately every decade, culminating in the upcoming launch of the VISUMAX 800 and SMILE pro in 2025 [8][12] - The new femtosecond laser 4.0 technology offers enhanced precision and customization, with a higher average transaction price compared to previous versions [9][10] - The all-light sculpting technique utilizes a 3D model of the eye and AI algorithms for personalized treatment, marking a significant advancement in refractive surgery [14] Group 4 - The refractive surgery market is expected to see a dual impact on performance and valuation due to technological upgrades and the release of pent-up demand [1][41] - The average age of patients undergoing refractive surgery in China is significantly lower than in Europe, indicating a different demographic focus and potential for market expansion [37][38] - The introduction of new materials like EVO+ICL (V5) and Longjing PR is expected to enhance visual quality and safety for patients, further driving market growth [21][27]